AstraZeneca Cash Flow Statement
View: Annual
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 8,742.0 | 7,510.0 | 7,693.0 |
| Net Investing Cash Flow | (3,896.0) | (14,887.0) | (272.0) |
| Net Financing Cash Flow | (6,362.0) | 6,051.0 | (5,366.0) |
| Net Change in Cash | (1,516.0) | (1,326.0) | 2,055.0 |
| Depreciation & Amortization | 2,620.0 | 1,856.0 | 1,345.0 |
| Capital Expenditures | (1,095.0) | (1,130.0) | (794.0) |
| Cash Dividends Paid | (2,739.0) | (2,641.0) | (2,220.0) |
© 2009 Morningstar, Inc. Financial Data provided by
